Correlation Between Tarsus Pharmaceuticals and MGIC Investment

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and MGIC Investment at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and MGIC Investment into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and MGIC Investment Corp, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and MGIC Investment and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of MGIC Investment. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and MGIC Investment.

Diversification Opportunities for Tarsus Pharmaceuticals and MGIC Investment

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between Tarsus and MGIC is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and MGIC Investment Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MGIC Investment Corp and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with MGIC Investment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MGIC Investment Corp has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and MGIC Investment go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and MGIC Investment

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 1.92 times more return on investment than MGIC Investment. However, Tarsus Pharmaceuticals is 1.92 times more volatile than MGIC Investment Corp. It trades about 0.28 of its potential returns per unit of risk. MGIC Investment Corp is currently generating about 0.06 per unit of risk. If you would invest  3,967  in Tarsus Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of  857.00  from holding Tarsus Pharmaceuticals or generate 21.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  MGIC Investment Corp

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
MGIC Investment Corp 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in MGIC Investment Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, MGIC Investment is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Tarsus Pharmaceuticals and MGIC Investment Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and MGIC Investment

The main advantage of trading using opposite Tarsus Pharmaceuticals and MGIC Investment positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, MGIC Investment can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MGIC Investment will offset losses from the drop in MGIC Investment's long position.
The idea behind Tarsus Pharmaceuticals and MGIC Investment Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm